Vimarsana
Biggest News Aggregation in the World

Page 3 - Humanigen Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Humanigen Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Humanigen Inc Today - Breaking & Trending Today

Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket - Vimarsana News

Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket

Gainers Evelo Biosciences, Inc. (NASDAQ:EVLO) shares gained 192.8% to $0.2427 in pre-market trading. Evelo Biosciences was granted U.S. patent #...

Humanigen (NASDAQ:HGEN) Stock Price Up 11.9% - Vimarsana News

Humanigen (NASDAQ:HGEN) Stock Price Up 11.9%

Humanigen, Inc. (NASDAQ:HGEN – Get Rating) shares rose 11.9% during mid-day trading on Tuesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 2,224,434 shares were traded during trading, a decline of 5% from the average daily volume of 2,341,994 shares. The stock had previously closed at $0.15. Analysts Set […]

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia - Vimarsana News

PREACH-M trial: Lenzilumab may improve treatment response in chronic myelomonocytic leukemia

Humanigen, Inc.today extended previously reported results by presenting additional, statistically significant hematologic improvements and reductions in inflammatory markers from lenzilumab, its investigational drug, in a Phase 2/3 trial of treatment-naïve participants with chronic myelomonocytic leukemia and RAS-pathway mutations.

Cellectis S A : Report of the board of directors to the combined shareholders' meeting - June 27, 2023 - Vimarsana News

Cellectis S A : Report of the board of directors to the combined shareholders' meeting - June 27, 2023

CELLECTIS A corporation with a share capital of 2,779,188.40 euros Headquarters: 8, rue de la Croix Jarry - 75013 Paris ... | June 1, 2023

Superior Drilling Products (NYSE:SDPI) Earns Buy Rating from Analysts at StockNews.com - Vimarsana News

Superior Drilling Products (NYSE:SDPI) Earns Buy Rating from Analysts at StockNews.com

Credit Suisse Group restated their underperform rating on shares of Humanigen (NASDAQ:HGEN – Get Rating) in a report issued on Monday morning, Benzinga reports. The firm currently has a $0.50 price objective on the stock. Separately, Cantor Fitzgerald initiated coverage on Humanigen in a research report on Wednesday, January 11th. They set a neutral rating […]